Insights

3 ASX health care shares that outpaced the market on Friday

These three healthcare shares had a better day than the broader index.
The post 3 ASX health care shares that outpaced the market on Friday appeared first on The Motley Fool Australia. –

The benchmark S&P/ASX 200 Index (ASX: XJO) finished up 0.17% at 7,392 points after spending most of the week in the red.

Even with the gain, three ASX health care shares stood out today, with each posting returns that outpaced the market.

Here is the rundown on what happened with each today.

Trajan Group Holdings Ltd (ASX: TRJ)

Shares in global analytical science and device company Trajan Group jumped over 8% today and finished near an all-time high.

Investors bought into the company’s shares after it announced it had completed the acquisition of German company Axel Semrau overnight.

The company completed the deal on a consideration of 17 million euros. This gives the company further exposure to the European markets.

The Axel Semrau company manufactures laboratory automation and chromatography software and detection systems. The company reported FY21 (year ended Sept 2021) revenues of 14.9 million euros and EBITDA of 1.46 million euros.

Trajan shares traded as high as 8% late in the session today, after climbing gradually from the open.

Early investors have been rewarded with their holdings in Trajan group. Its share price has gained over 105% since listing in early July.

SDI Limited (ASX: SDI)

Shares in supplier of dental restoration materials SDI traded as much as 7% higher before dumping just before the closing bell today.

At market close, SDI’s shares are fetching $1.07 apiece and are up only 1.90%. They were on the move as Investors responded positively to the company’s AGM release today.

In its address, the company’s chairman Jeffery Cheetham gave an overview of the company’s operations for the year. He also addressed how the firm has created value for its shareholders in that time.

For instance, SDI declared a final dividend of 1.65 cents per share on top of its interim dividend of 1.5 cents per share. Combined, this signified a 70.3% growth in the dividend payout ratio from the previous year.

SDI also launched several new products in its whitening and glass ionomer range and continues to invest in research development, as per its report.

The SDI share price has gained over 31% in the past 12 months after rallying another 36% this year to date.

Bcal Diagnostics Ltd (ASX: BDX)

Shares in Bcal Diagnostics hit an intraday high of 15.2 cents in early trade today and held course until the finish.

The gains are a welcomed turn for Bcal shareholders, who have lost 39% in the past few months since the company listed.

There wasn’t any price-sensitive news out of Bcal’s camp today, however, its share price has been on the downward slope for the last few weeks.

But, the company did release trial results for its BCAL test early in the month. That data readout supported and reinforced previous studies conducted by the company.

Bcal advised its BCAL test showed positive results in samples obtained from a recent Cohort 4 test. The company is now seeking to further refine its BCAL algorithm and biomarker development.

Investors have bought in at the lows today and volume is about 50% of the company’s 4-week average volume for number of shares traded.

ASX health care shares have done well across the board today as well. The S&P/ASX 200 Health Care index (ASX: XHJ) finished up around 1%, after gaining more than 6% in the past month, indicating strengths across the broad sector.

The post 3 ASX health care shares that outpaced the market on Friday appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

IPO flop: Tissue Repair (ASX:TRP) share price plunges 40% since listing

The Treasury Wine (ASX:TWE) share price popped some corks to a new 5-week high today

Here are the top 10 ASX shares today

Why is the Starpharma (ASX:SPL) share price trading at 52-week lows?

Ventia (ASX:VNT) share price surged 25% following IPO

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended SDI Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!